{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T03:43:56Z","timestamp":1777520636775,"version":"3.51.4"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2017,8,30]],"date-time":"2017-08-30T00:00:00Z","timestamp":1504051200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"name":"AZTherapies, Inc."}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Drug Investig"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1007\/s40261-017-0549-5","type":"journal-article","created":{"date-parts":[[2017,8,30]],"date-time":"2017-08-30T16:59:21Z","timestamp":1504112361000},"page":"1025-1034","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["Pharmacokinetics of Cromolyn and Ibuprofen in Healthy Elderly Volunteers"],"prefix":"10.1007","volume":"37","author":[{"given":"David","family":"Brazier","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Perry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jim","family":"Keane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katie","family":"Barrett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David R.","family":"Elmaleh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,8,30]]},"reference":[{"issue":"4","key":"549_CR1","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.jalz.2016.03.001","volume":"12","author":"A Alzheimer\u2019s","year":"2016","unstructured":"Alzheimer\u2019s A. Alzheimer\u2019s disease facts and figures. Alzheimers Dement. 2016;12(4):459\u2013509.","journal-title":"Alzheimers Dement"},{"issue":"1","key":"549_CR2","doi-asserted-by":"crossref","first-page":"75","DOI":"10.3233\/JAD-2001-3111","volume":"3","author":"DJ Selkoe","year":"2001","unstructured":"Selkoe DJ. Alzheimer\u2019s disease results from the cerebral accumulation and cytotoxicity of amyloid beta-protein. J Alzheimers Dis. 2001;3(1):75\u201380.","journal-title":"J Alzheimers Dis"},{"issue":"7","key":"549_CR3","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.ijdevneu.2004.07.013","volume":"22","author":"J Gotz","year":"2004","unstructured":"Gotz J, Schild A, Hoerndli F, Pennanen L. Amyloid-induced neurofibrillary tangle formation in Alzheimer\u2019s disease: insight from transgenic mouse and tissue-culture models. Int J Dev Neurosci. 2004;22(7):453\u201365.","journal-title":"Int J Dev Neurosci"},{"issue":"5","key":"549_CR4","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1007\/s00401-010-0679-9","volume":"119","author":"GK Gouras","year":"2010","unstructured":"Gouras GK, Tampellini D, Takahashi RH, Capetillo-Zarate E. Intraneuronal beta-amyloid accumulation and synapse pathology in Alzheimer\u2019s disease. Acta Neuropathol. 2010;119(5):523\u201341.","journal-title":"Acta Neuropathol"},{"key":"549_CR5","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1186\/1742-2094-9-151","volume":"9","author":"D Krstic","year":"2012","unstructured":"Krstic D, Madhusudan A, Doehner J, Vogel P, Notter T, Imhof C, et al. Systemic immune challenges trigger and drive Alzheimer-like neuropathology in mice. J Neuroinflammation. 2012;9:151. doi: 10.1186\/1742-2094-9-151 .","journal-title":"J Neuroinflammation"},{"key":"549_CR6","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/1742-2094-2-22","volume":"2","author":"MT Heneka","year":"2005","unstructured":"Heneka MT, Sastre M, Dumitrescu-Ozimek L, Dewachter I, Walter J, Klockgether T, et al. Focal glial activation coincides with increased BACE1 activation and precedes amyloid plaque deposition in APP[V717I] transgenic mice. J Neuroinflammation. 2005;2:22.","journal-title":"J Neuroinflammation"},{"key":"549_CR7","first-page":"19","volume":"1","author":"BP Imbimbo","year":"2010","unstructured":"Imbimbo BP, Solfrizzi V, Panza F. Are NSAIDs useful to treat Alzheimer\u2019s disease or mild cognitive impairment? Front Aging Neurosci. 2010;2:19.","journal-title":"Front Aging Neurosci"},{"key":"549_CR8","doi-asserted-by":"crossref","first-page":"24","DOI":"10.3410\/M3-24","volume":"3","author":"WS Griffin","year":"2011","unstructured":"Griffin WS. Alzheimer\u2019s\u2014looking beyond plaques. F1000 Med Rep. 2011;3:24.","journal-title":"F1000 Med Rep"},{"issue":"1","key":"549_CR9","doi-asserted-by":"crossref","first-page":"57","DOI":"10.2174\/187152711794488665","volume":"10","author":"JJ Hoozemans","year":"2011","unstructured":"Hoozemans JJ, Veerhuis R, Rozemuller JM, Eikelenboom P. Soothing the inflamed brain: effect of non-steroidal anti-inflammatory drugs on Alzheimer\u2019s disease pathology. CNS Neurol Disord Drug Targets. 2011;10(1):57\u201367.","journal-title":"CNS Neurol Disord Drug Targets"},{"issue":"12","key":"549_CR10","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1038\/nrn3114","volume":"12","author":"BV Zlokovic","year":"2011","unstructured":"Zlokovic BV. Neurovascular pathways to neurodegeneration in Alzheimer\u2019s disease and other disorders. Nat Rev Neurosci. 2011;12(12):723\u201338.","journal-title":"Nat Rev Neurosci"},{"issue":"20","key":"549_CR11","doi-asserted-by":"crossref","first-page":"7504","DOI":"10.1523\/JNEUROSCI.23-20-07504.2003","volume":"23","author":"Q Yan","year":"2003","unstructured":"Yan Q, Zhang J, Liu H, Babu-Khan S, Vassar R, Biere AL, et al. Anti-inflammatory drug therapy alters beta-amyloid processing and deposition in an animal model of Alzheimer\u2019s disease. J Neurosci. 2003;23(20):7504\u20139.","journal-title":"J Neurosci"},{"issue":"9","key":"549_CR12","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1038\/nrd3505","volume":"10","author":"E Karran","year":"2011","unstructured":"Karran E, Mercken M, De Strooper B. The amyloid cascade hypothesis for Alzheimer\u2019s disease: an appraisal for the development of therapeutics. Nat Rev Drug Discov. 2011;10(9):698\u2013712.","journal-title":"Nat Rev Drug Discov"},{"issue":"3","key":"549_CR13","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1111\/j.1471-4159.2004.02743.x","volume":"91","author":"L Gasparini","year":"2004","unstructured":"Gasparini L, Ongini E, Wenk G. Non-steroidal anti-inflammatory drugs (NSAIDs) in Alzheimer\u2019s disease: old and new mechanisms of action. J Neurochem. 2004;91(3):521\u201336.","journal-title":"J Neurochem"},{"issue":"4","key":"549_CR14","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1074\/jbc.M114.586602","volume":"290","author":"Y Hori","year":"2015","unstructured":"Hori Y, Takeda S, Cho H, Wegmann S, Shoup TM, Takahashi K, et al. A food and drug administration-approved asthma therapeutic agent impacts amyloid beta in the brain in a transgenic model of Alzheimer disease. J Biol Chem. 2015;290(4):1966\u201378.","journal-title":"J Biol Chem"},{"key":"549_CR15","unstructured":"Elmaleh DR, Shoup TM, Fischman AJ, Takahashi K, Larvie M, Vogan E. Evaluation of F-18 radiolabeled cromolyn as a potential A\u03b2 polymerization inhibitor and PET tracer. HAI (Human Amyloid Imaging), Miami Florida. 2014. p. 63."},{"issue":"3","key":"549_CR16","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1016\/S0022-5347(25)00213-7","volume":"241","author":"R Richards","year":"1987","unstructured":"Richards R, Dickson CR, Renwick AG, Lewis RA, Holgate ST. Absorption and disposition kinetics of cromolyn sodium and the influence of inhalation technique. J Pharmacol Exp Ther. 1987;241(3):1028\u201332.","journal-title":"J Pharmacol Exp Ther"},{"issue":"6","key":"549_CR17","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1046\/j.1365-2125.1999.00937.x","volume":"47","author":"OA Aswania","year":"1999","unstructured":"Aswania OA, Corlett SA, Chrystyn H. Relative bioavailability of sodium cromoglycate to the lung following inhalation, using urinary excretion. Br J Clin Pharmacol. 1999;47(6):613\u20138.","journal-title":"Br J Clin Pharmacol"},{"issue":"1","key":"549_CR18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1517\/17425247.2010.542141","volume":"8","author":"M Keller","year":"2011","unstructured":"Keller M, Schierholz J. Have inadequate delivery systems hampered the clinical success of inhaled disodium cromoglycate? Time for reconsideration. Expert Opin Drug Deliv. 2011;8(1):1\u201317.","journal-title":"Expert Opin Drug Deliv"},{"issue":"21","key":"549_CR19","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1056\/NEJMoa010178","volume":"345","author":"BA In\u2019t Veld","year":"2001","unstructured":"In\u2019t Veld BA, Ruitenberg A, Hofman A, Launer LJ, van Duijn CM, Stijnen T, et al. Nonsteroidal antiinflammatory drugs and the risk of Alzheimer\u2019s disease. N Engl J Med. 2001;345(21):1515\u201321.","journal-title":"N Engl J Med"},{"issue":"7407","key":"549_CR20","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1136\/bmj.327.7407.128","volume":"327","author":"M Etminan","year":"2003","unstructured":"Etminan M, Gill S, Samii A. Effect of non-steroidal anti-inflammatory drugs on risk of Alzheimer\u2019s disease: systematic review and meta-analysis of observational studies. BMJ. 2003;327(7407):128. doi: 10.1136\/bmj.327.7407.128 .","journal-title":"BMJ"},{"issue":"4","key":"549_CR21","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1212\/WNL.50.4.986","volume":"50","author":"IR Mackenzie","year":"1998","unstructured":"Mackenzie IR, Munoz DG. Nonsteroidal anti-inflammatory drug use and Alzheimer-type pathology in aging. Neurology. 1998;50(4):986\u201390.","journal-title":"Neurology"},{"issue":"1","key":"549_CR22","doi-asserted-by":"crossref","first-page":"37","DOI":"10.3233\/JAD-2000-2105","volume":"2","author":"I Alafuzoff","year":"2000","unstructured":"Alafuzoff I, Overmyer M, Helisalmi S, Soininen H. Lower counts of astroglia and activated microglia in patients with Alzheimer\u2019s disease with regular use of non-steroidal anti-inflammatory drugs. J Alzheimers Dis. 2000;2(1):37\u201346.","journal-title":"J Alzheimers Dis"},{"issue":"6860","key":"549_CR23","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1038\/35102591","volume":"414","author":"S Weggen","year":"2001","unstructured":"Weggen S, Eriksen JL, Das P, Sagi SA, Wang R, Pietrzik CU, et al. A subset of NSAIDs lower amyloidogenic Abeta42 independently of cyclooxygenase activity. Nature. 2001;414(6860):212\u20136.","journal-title":"Nature"},{"issue":"Pt 3","key":"549_CR24","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1093\/brain\/awn008","volume":"131","author":"LA Kotilinek","year":"2008","unstructured":"Kotilinek LA, Westerman MA, Wang Q, Panizzon K, Lim GP, Simonyi A, et al. Cyclooxygenase-2 inhibition improves amyloid-beta-mediated suppression of memory and synaptic plasticity. Brain. 2008;131(Pt 3):651\u201364.","journal-title":"Brain"},{"key":"549_CR25","unstructured":"https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02547818 . Accessed June 2017."},{"issue":"2","key":"549_CR26","doi-asserted-by":"publisher","first-page":"101","DOI":"10.2165\/00003088-199834020-00002","volume":"34","author":"NM Davies","year":"1998","unstructured":"Davies NM. Clinical pharmacokinetics of ibuprofen. The first 30 years. Clin Pharmacokinet. 1998;34(2):101\u201354. doi: 10.2165\/00003088-199834020-00002 .","journal-title":"Clin Pharmacokinet"},{"issue":"3","key":"549_CR27","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1111\/j.1365-2125.1995.tb05783.x","volume":"40","author":"B Bannwarth","year":"1995","unstructured":"Bannwarth B, Lapicque F, Pehourcq F, Gillet P, Schaeverbeke T, Laborde C, et al. Stereoselective disposition of ibuprofen enantiomers in human cerebrospinal fluid. Br J Clin Pharmacol. 1995;40(3):266\u20139.","journal-title":"Br J Clin Pharmacol"},{"issue":"4","key":"549_CR28","doi-asserted-by":"crossref","first-page":"e1002","DOI":"10.1542\/peds.2007-0064","volume":"120","author":"H Kokki","year":"2007","unstructured":"Kokki H, Kumpulainen E, Lehtonen M, Laisalmi M, Heikkinen M, Savolainen J, et al. Cerebrospinal fluid distribution of ibuprofen after intravenous administration in children. Pediatrics. 2007;120(4):e1002\u20138.","journal-title":"Pediatrics"},{"issue":"9","key":"549_CR29","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1002\/jcph.307","volume":"54","author":"R Har-Even","year":"2014","unstructured":"Har-Even R, Stepensky D, Britzi M, Soback S, Chaim AB, Brandriss N, et al. Plasma and cerebrospinal fluid concentrations of ibuprofen in pediatric patients and antipyretic effect: Pharmacokinetic-pharmacodynamic modeling analysis. J Clin Pharmacol. 2014;54(9):1023\u201330.","journal-title":"J Clin Pharmacol"}],"container-title":["Clinical Drug Investigation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40261-017-0549-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40261-017-0549-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40261-017-0549-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,25]],"date-time":"2025-06-25T09:01:36Z","timestamp":1750842096000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40261-017-0549-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8,30]]},"references-count":29,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2017,11]]}},"alternative-id":["549"],"URL":"https:\/\/doi.org\/10.1007\/s40261-017-0549-5","relation":{},"ISSN":["1173-2563","1179-1918"],"issn-type":[{"value":"1173-2563","type":"print"},{"value":"1179-1918","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,8,30]]}}}